X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (37) 37
humans (34) 34
oncology (21) 21
cancer (19) 19
stomach neoplasms - genetics (16) 16
stomach cancer (15) 15
gene expression (14) 14
genetic aspects (14) 14
tumors (14) 14
mutation (13) 13
prognosis (13) 13
patients (12) 12
male (11) 11
research (11) 11
colorectal cancer (10) 10
female (10) 10
middle aged (10) 10
cell line, tumor (9) 9
chemotherapy (9) 9
expression (9) 9
gastric cancer (9) 9
genomes (9) 9
adenocarcinoma (8) 8
aged (8) 8
gastroenterology & hepatology (8) 8
gene expression regulation, neoplastic (8) 8
stomach neoplasms - drug therapy (8) 8
abridged index medicus (7) 7
adult (7) 7
analysis (7) 7
carcinoma (7) 7
care and treatment (7) 7
genes (7) 7
genomics (7) 7
health aspects (7) 7
stomach neoplasms - metabolism (7) 7
stomach neoplasms - pathology (7) 7
adenocarcinoma - genetics (6) 6
biomarkers, tumor - genetics (6) 6
development and progression (6) 6
gene expression profiling (6) 6
genetics & heredity (6) 6
medical prognosis (6) 6
aged, 80 and over (5) 5
antineoplastic agents - therapeutic use (5) 5
biomarkers, tumor - metabolism (5) 5
cancer therapies (5) 5
classification (5) 5
gene-expression (5) 5
genetics (5) 5
mortality (5) 5
multidisciplinary sciences (5) 5
patient outcomes (5) 5
proteins (5) 5
studies (5) 5
survival analysis (5) 5
adenocarcinoma - metabolism (4) 4
antineoplastic agents - pharmacology (4) 4
cell biology (4) 4
cells (4) 4
colorectal carcinoma (4) 4
colorectal neoplasms - genetics (4) 4
deoxyribonucleic acid--dna (4) 4
gastroenterology and hepatology (4) 4
medicine, research & experimental (4) 4
metastasis (4) 4
methods (4) 4
microsatellite instability (4) 4
retrospective studies (4) 4
risk factors (4) 4
stem cells (4) 4
surgery (4) 4
transcriptome (4) 4
adenocarcinoma - drug therapy (3) 3
adjuvant treatment (3) 3
algorithms (3) 3
animals (3) 3
bioinformatics (3) 3
case-control studies (3) 3
cell proliferation (3) 3
clinical trials (3) 3
cluster analysis (3) 3
colon-cancer (3) 3
colorectal neoplasms - pathology (3) 3
copy number (3) 3
diagnosis (3) 3
dna methylation - genetics (3) 3
drug therapy (3) 3
exome - genetics (3) 3
fluorouracil (3) 3
gene amplification (3) 3
gene deletion (3) 3
gene mutations (3) 3
hematology, oncology and palliative medicine (3) 3
hepatocellular-carcinoma (3) 3
heterogeneity (3) 3
immunology (3) 3
in situ hybridization, fluorescence (3) 3
kaplan-meier estimate (3) 3
liver cancer (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Letters, ISSN 0304-3835, 10/2014, Volume 353, Issue 2, p. 167
  Gastric cancer (GC) is a major cause of global cancer mortality. Previous genomic studies have reported that several RTK-RAS pathway components are amplified... 
Biomedical research | Breast cancer | Artificial chromosomes | Patients | Stomach cancer | Proteins | Studies | Survival analysis | Biopsy | Surgery | Medical prognosis | Classification | Mutation | Deoxyribonucleic acid--DNA | Tumors
Journal Article
Nature Genetics, ISSN 1061-4036, 05/2017, Volume 49, Issue 5, pp. 708 - 718
Journal Article
Gut, ISSN 0017-5749, 05/2012, Volume 61, Issue 5, pp. 673 - 684
ObjectiveGastric cancer is a major gastrointestinal malignancy for which targeted therapies are emerging as treatment options. This study sought to identify... 
GROWTH-FACTOR RECEPTOR | LUNG | AMPLIFICATION | COPY-NUMBER | ACQUIRED-RESISTANCE | TYROSINE KINASE INHIBITOR | GASTROENTEROLOGY & HEPATOLOGY | TRASTUZUMAB RESISTANCE | EXPRESSION | LINEAGE-SURVIVAL ONCOGENE | GENETIC ALTERATIONS | Stomach Neoplasms - genetics | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Oligonucleotide Array Sequence Analysis | Receptor, ErbB-2 - genetics | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Antineoplastic Agents - therapeutic use | Genetic Markers | Stomach Neoplasms - drug therapy | Molecular Targeted Therapy | Proto-Oncogene Proteins c-met - genetics | Gene Amplification | Gene Deletion | Polymorphism, Single Nucleotide | Stomach Neoplasms - mortality | Receptor, Fibroblast Growth Factor, Type 2 - genetics | Development and progression | Drug targeting | Genetic aspects | Research | Demographic aspects | Stomach cancer | Proteins | Studies | Chemotherapy | Medical prognosis | Mortality | Clinical trials | Breast cancer | Mutation | Cancer therapies | Patients | Tumors | Index Medicus | Abridged Index Medicus | Stomach | gastroscopy | Barrett's metaplasia | gastric cancer | targeted therapies | gene mutation | gastric pre-cancer | chemotherapy | oesophageal cancer | Barrett's carcinoma | receptor tyrosine kinases | cell signalling | gastrointestinal cancer | cancer | colorectal cancer screening | gastrointesinal endoscopy | gastric carcinoma | 1506 | molecular pathology | copy number alterations | gene expression
Journal Article
Nature Genetics, ISSN 1061-4036, 05/2012, Volume 44, Issue 5, pp. 570 - 574
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2013, Volume 145, Issue 3, pp. 554 - 565
Background & Aims Almost all gastric cancers are adenocarcinomas, which have considerable heterogeneity among patients. We sought to identify subtypes of... 
Gastroenterology and Hepatology | Stomach Cancer | Personalized Cancer Treatment | Cancer Classification | PI3K | GC-Class | Keywords Stomach Cancer GC-Class Personalized Cancer Treatment Cancer Classification PI3K | STEM-CELLS | DNA HYPOMETHYLATION | ADENOCARCINOMA | STOMACH-CANCER | TUMORS | CHEMOTHERAPY | CLASS DISCOVERY | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | CARCINOMA | REVEALS | Adenocarcinoma - classification | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Stomach Neoplasms - metabolism | Antineoplastic Agents - therapeutic use | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | TOR Serine-Threonine Kinases - antagonists & inhibitors | Fluorouracil - therapeutic use | Adenocarcinoma - metabolism | Biomarkers, Tumor - metabolism | Adenocarcinoma - genetics | Retrospective Studies | Stomach Neoplasms - classification | Stomach Neoplasms - genetics | Genetic Association Studies | Treatment Outcome | Models, Statistical | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Regression Analysis | Bayes Theorem | Survival Analysis | Cell Line, Tumor | Aged | Biomarkers, Tumor - genetics | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Cluster Analysis | Medical colleges | Chemotherapy | College graduates | Stem cells | Stomach cancer | Cancer | Fluorouracil | Index Medicus | Abridged Index Medicus
Journal Article
Nature Medicine, ISSN 1078-8956, 06/2016, Volume 22, Issue 6, pp. 666 - 671
Journal Article
Gut, ISSN 0017-5749, 11/2015, Volume 64, Issue 11, pp. 1721 - 1731
Journal Article
Nature, ISSN 0028-0836, 05/2018, Volume 557, Issue 7706, pp. 575 - 579
Various forms of immunotherapy, such as checkpoint blockade immunotherapy, are proving to be effective at restoring T cell-mediated immune responses that can... 
HETEROGENEITY | RESPONSES | IMMUNOTHERAPY | LANDSCAPE | MULTIDISCIPLINARY SCIENCES | NEOANTIGENS | PD-1 | ANTITUMOR | EXHAUSTION | Index Medicus
Journal Article
Journal Article